Authors


Machaon Bonafede, PhD, MPH

Latest:

Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis

For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.



Jan D. Hirsch, RPh, PhD

Latest:

Comparison of Pharmacists and Primary Care Providers as Immunizers

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.


Ken Whittemore, Jr

Latest:

New Tools for a New Normal in Pharmacy

Pharmacists need new tools to reduce administrative burden and provide the best care to patients.


Dawn Moore Jefferson, PharmD

Latest:

Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)

The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.



Melissa Skelton Duke, PharmD, MS, BCPS

Latest:

How Integrated Health Care Delivery Networks Collaborate to Optimize Specialty Pharmacy Care

As the number of specialty drugs has grown in the past decade, regional health systems and academic medical centers have stepped up to assert the power of integration and coordinated care by establishing and expanding their own specialty pharmacies.


Jeanette Y. Wick, RPh, MBA, FASCP

Latest:

Adherence and Compliance: You Say Tomato, I Say ToMAHto

Whatever it's called, failure to take medication as prescribed is widespread, but pharmacists can help.


Mark Bounthavong, PharmD

Latest:

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.


Meena Gella, OMS IV

Latest:

Exercise: Another Potential Option for Substance Abuse Disorder

Exercise improves psychological, behavioral, neurobiological, and overall health of patients.


Caitlin Mollison, Senior Editor

Latest:

Data Suggest Combination Abilities of OP-1250, Palbociclib for Breast Cancer at SABCS

OP-1250 and palbociclib showed “enhanced suppression of tumor growth” in preclinical mouse model studies, according to expert who presented his findings in a poster at the San Antonio Breast Cancer Symposium 2022.



Mary K. Caffrey, AJMC

Latest:

AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging Population

The annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.


JoAnn Stubbings, MHCA

Latest:

Biologic Management for IBD

With increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.


Libin Philip, PharmD

Latest:

PARP Inhibitors: A Novel Approach to Treating Ovarian Cancer

PARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.



Kate Gainer, PharmD

Latest:

My Burnout Story

I am grateful to those who identified my burnout and supported me to make changes and reverse the syndrome.


Ronnie DePue, RPh, CGP

Latest:

MTM Spotlights Pharmacy's Patient Counseling Role

Pharmacists are in the perfect position to influence patients and improve outcomes with medication therapy management.


Daniela E. Myers, MPH

Latest:

Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin

Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.


Caryn Domenici Belisle, RPh, Alka Patel, PharmD

Latest:

Takeda Pharmaceuticals America, Inc's Edarbi

The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.


Alexander Kantorovich, PharmD, BCPS

Latest:

Which Left Ventricular Assist Device Is Best?

Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.


Quintin Jessee, RPh, DPh

Latest:

Changes Coming in Specialty Pharmacy Accreditation

If you're not accredited with any of the major players, you could instantly lose out on future business growth opportunities.


F. Thomas Kaplan, MD

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Jean Chang, BS

Latest:

Telephone-Based Cardiovascular Medication Therapy Management in Medicare Part D Enrollees With Diabetes

A telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.


Michael C. Wisotsky, PharmD, RPh

Latest:

Hepatitis C

Achieving a sustained viral response in patients with hepatitis C is showed to reduce the risk of liver cancer.


Michael S. Kirkbride, PharmD, Option Care Health, vice president of Specialty

Latest:

Infusion Pharmacist Expertise Vital in Helping Manage IG Shortages, Ensuring Right Drug Gets to the Right Patient at the Right Dose

Perceived as the new “wonder drug,” immunoglobulin (IG) is a go-to therapy for healthcare providers seeking to bolster their patients’ immune systems; however, as demand grows, particularly for oncology and off-label indications, the supply can’t keep pace.


Maura McGuire, MD

Latest:

Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty Practice

While warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.


Sarah Scoular, PharmD, BCPS

Latest:

Sustainable Health Care in Developing Nations

Sarah Scoular, PharmD, BCPS, assistant professor at the University of Colorado Skaggs School of Pharmacy, discusses some of the international work she has been involved in.


Ryan Stept, MSc

Latest:

Specialty Pharmacy: A Five-Pronged Approach to Managing Cost

Specialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.